tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate manufacturers
- Palbociclib Impurity 3
-
- $0.00 / 10mg
-
2025-09-25
- CAS:1651214-74-2
- Min. Order: 10mg
- Purity: 98%
- Supply Ability: 500mg
|
| | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate Basic information |
| Product Name: | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | | Synonyms: | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate;4-[6-[(6-Acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-1-piperazinecarboxylic acid 1,1-dimethylethyl ester;8-Cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-6-vinyl-8H-pyrido[2,3-d]pyrimidin-7-one;Palbociclib-008;Pabociclib Impurity B;Palbociclib impurity 9/tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate;1-Piperazinecarboxylic acid, 4-[6-[(6-acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-, 1,1-dimethylethyl ester;tert-butyl 4-[6-({6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7H,8 H-pyrido[2,3-d]pyrimidin-2-yl}amino)pyridin-3-yl]p iperazine-1-carboxylate | | CAS: | 1651214-74-2 | | MF: | C29H37N7O4 | | MW: | 547.65 | | EINECS: | | | Product Categories: | | | Mol File: | 1651214-74-2.mol | ![tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate Structure](CAS/20180629/GIF/1651214-74-2.gif) |
| | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate Chemical Properties |
| Boiling point | 746.4±70.0 °C(Predicted) | | density | 1.294±0.06 g/cm3(Predicted) | | pka | 5.24±0.10(Predicted) | | InChIKey | QVJKVBFRYVEWGO-UHFFFAOYSA-N | | SMILES | N1(C(OC(C)(C)C)=O)CCN(C2=CC=C(NC3=NC=C4C(C)=C(C(C)=O)C(=O)N(C5CCCC5)C4=N3)N=C2)CC1 |
| | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate Usage And Synthesis |
| Uses | N-Boc Palbociclib is a protected Palbociclib (P139900),(also known as compound number PD-0332991) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| | tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate Preparation Products And Raw materials |
|